Ms. Iru Paudel, graduate student from the Department of Cellular Biology and Pharmacology, has been selected to receive a prestigious Postdoctoral and Graduate Student Travel Award to present her research entitled “Identification of novel chemotherapies targeting mitochondria-cell communication” at the American Society for Biochemistry and Molecular Biology’s (ASBMB) Annual Meeting. Ms. Paudel was awarded this honor based on the scientific merit of her project, which uses a novel screen to discover chemicals for the treatment of chemotherapy-resistant ovarian cancer. To date, she has identified six new chemical families that enhance chemotherapies in resistant cell lines.
As part of her travel award, Ms. Paudel will participate in an awardee reception with other graduate students and postdoctoral associates. She will also participate in a career development workshop held concurrently with the ASBMB annual meeting. As part of this workshop, Iru will have an opportunity to network with world-renowned scientists in attendance.
Also, Ms. Paudel has been selected to give an oral presentation at the Florida Drug Discovery Acceleration Program Collaborator Conference on January 23rd in Port St. Lucie, FL.
Iru’s research is supervised by her graduate advisor and committee which includes Drs. Jeremy Chambers, (Department of Cellular Biology and Pharmacology), Dietrich Lorke (Department of Cellular Biology and Pharmacology), Helen Tempest (Department of Human and Molecular Genetics), Fenfei Leng (Department of Chemistry and Biochemistry), and Douglas Green (Department of Immunology, St. Jude Children’s Research Hospital). The guidance of these faculty have helped Ms. Paudel develop her project into the impactful study recognized by the ASBMB. Iru’s work is currently supported by a grant from Hearing the Ovarian Cancer Whisper.
Congratulations to Ms. Iru Padel !